Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumati Gupta

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
The Oncologist|March 7, 2024
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR)Kamal Kant Sahu, Haoran Li, Vinay Mathew Thomas, et al.
Oncotarget|April 22, 2017
Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implicationsAndrew W Hahn, David M Gill, Benjamin Maughan, et al.
Journal of the National Cancer Institute|December 12, 2017
Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control StudyChristopher Martin, Claire L Leiser, Brock O'Neil, et al.
Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
The Oncologist|March 23, 2023
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell CarcinomaHaoran Li, Kamal Kant Sahu, James Brundage, et al.
Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 27, 2020
Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer RiskHeidi A Hanson, Claire L Leiser, Brock O'Neil, et al.
Ecancermedicalscience|October 13, 2016
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2David M Gill, David D Stenehjem, Kinjal Parikh, et al.
European Urology Oncology|April 30, 2025
Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab TrialRohit K Jain, Umang Swami, Mehmet A Bilen, et al.
Clinical Genitourinary Cancer|December 25, 2024
Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial CarcinomaNicolas Sayegh, Yeonjung Jo, Georges Gebrael, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
The Oncologist|March 7, 2024
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR)Kamal Kant Sahu, Haoran Li, Vinay Mathew Thomas, et al.
Oncotarget|April 22, 2017
Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implicationsAndrew W Hahn, David M Gill, Benjamin Maughan, et al.
Journal of the National Cancer Institute|December 12, 2017
Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control StudyChristopher Martin, Claire L Leiser, Brock O'Neil, et al.
Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
The Oncologist|March 23, 2023
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell CarcinomaHaoran Li, Kamal Kant Sahu, James Brundage, et al.
Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 27, 2020
Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer RiskHeidi A Hanson, Claire L Leiser, Brock O'Neil, et al.
Ecancermedicalscience|October 13, 2016
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2David M Gill, David D Stenehjem, Kinjal Parikh, et al.
European Urology Oncology|April 30, 2025
Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab TrialRohit K Jain, Umang Swami, Mehmet A Bilen, et al.
Clinical Genitourinary Cancer|December 25, 2024
Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial CarcinomaNicolas Sayegh, Yeonjung Jo, Georges Gebrael, et al.
Pageof 7